Dimensional Fund Advisors
NVLN

Dimensional Fund Advisors’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Dimensional Fund Advisors’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-56,270
Closed -$197K – 3393
2018
Q1 		$197K Sell
56,270
-183,866
-77% -$779K ﹤0.01% 3232
2017
Q4 		$749K Buy
+240,136
New +$1.15M ﹤0.01% 3039

Other funds holding NVLN

EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $320M AUM 140.1% 1-Year Est. Return

Dimensional Fund Advisors's NVLN Position: Q2 2018 in Review

Dimensional Fund Advisors sold out of Novelion Therapeutics Inc. Common Shares (NVLN) in Q2 2018, closing a stake of 56,270 shares — an estimated $197K sold.

Dimensional Fund Advisors first reported a position in NVLN in Q4 2017 and held it in 2 quarters. The position peaked at $749K in Q4 2017. 53 funds tracked by Wall St. Rank hold NVLN as of Q2 2018.

  • Dimensional Fund Advisors reported no remaining Novelion Therapeutics Inc. Common Shares position as of Q2 2018 after selling out during the quarter.
  • Dimensional Fund Advisors sold 56,270 Novelion Therapeutics Inc. Common Shares shares in Q2 2018, an estimated $197K.
  • Dimensional Fund Advisors first reported a position in Novelion Therapeutics Inc. Common Shares in Q4 2017 and held it in 2 quarters.
  • Dimensional Fund Advisors's Novelion Therapeutics Inc. Common Shares position peaked at $749K in Q4 2017.
  • 53 funds tracked by Wall St. Rank held Novelion Therapeutics Inc. Common Shares as of Q2 2018.

Based on Dimensional Fund Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.